Literature DB >> 35428909

Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ Treg cell interactions.

Ming Wang1, Zhongyu Qin2, Jiajia Wan3, Yan Yan3, Xixi Duan3, Xiaohan Yao3, Ziming Jiang4, Wenqing Li3, Zhihai Qin5,6.   

Abstract

BACKGROUND: Since the lung is one of the most common sites for cancer metastasis, it could provide a suitable microenvironment for pre-metastatic niche (PMN) formation to facilitate tumor cell colonization. Regulatory T cells (Tregs) are an immunosuppressive cell type found ubiquitously in tumors and may play a crucial role in PNM formation. In this study, we investigated tumor-derived exosome (TDE)-induced Treg differentiation in the lung PMN as well as the underlying mechanisms.
METHODS: TDEs were isolated from the Lewis lung carcinoma cell line (LLC-exo) and their effects on mouse pulmonary fibroblasts was investigated in vitro as well as on lung tumor formation and metastasis in a pre-injected mouse model. Immune cell populations in the lung were analyzed by flow cytometry. Expression of CCL1 and CCR8 was evaluated by immunofluorescence staining, qRT-PCR and Western blot analyses. Cytokine expression was measured using mouse cytokine arrays and ELISA.
RESULTS: The number of CD4+ FoxP3+ Tregs was significantly increased in lungs in a LLC-exo pre-injected mouse model. Lung fibroblasts secreted increased amounts of CCL1 after co-culture with LLC-exo, which induced Treg differentiation by activating its specific receptor CCR8, ultimately contributing to the establishment of an immunologically tolerant PMN. Moreover, inhibiting the release of LLC-exo by GW4869, or blocking the CCL1-CCR8 axis using AZ084, suppressed Tregs differentiation and tumor metastasis in the lung.
CONCLUSIONS: Collectively, our study provides a novel mechanism by which Tregs are activated to form an immunologically tolerant PMN and demonstrates a critical link among lung fibroblasts, Tregs and metastatic tumor cells.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CCL1–CCR8; Fibroblasts; Metastasis; PMN; Tregs

Mesh:

Substances:

Year:  2022        PMID: 35428909     DOI: 10.1007/s00262-022-03196-3

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


  2 in total

1.  Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Hye Suk Hwang; Yoonsuh Park; Ki-Hye Kim; Sang-Moo Kang
Journal:  Immune Netw       Date:  2020-11-25       Impact factor: 6.303

2.  TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment.

Authors:  Shusuke Kawashima; Takashi Inozume; Masahito Kawazu; Toshihide Ueno; Joji Nagasaki; Etsuko Tanji; Akiko Honobe; Takehiro Ohnuma; Tatsuyoshi Kawamura; Yoshiyasu Umeda; Yasuhiro Nakamura; Tomonori Kawasaki; Yukiko Kiniwa; Osamu Yamasaki; Satoshi Fukushima; Yuzuru Ikehara; Hiroyuki Mano; Yutaka Suzuki; Hiroyoshi Nishikawa; Hiroyuki Matsue; Yosuke Togashi
Journal:  J Immunother Cancer       Date:  2021-11       Impact factor: 12.469

  2 in total
  1 in total

Review 1.  The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.

Authors:  Dillon S Richardson; Jonathan M Spehar; David T Han; Prathik A Chakravarthy; Steven T Sizemore
Journal:  Cells       Date:  2022-05-14       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.